glp 1 based therapeutics summit 2nd GLP-1-Based The expanding benefits of GLP-1

Research has explored its activity in epithelial barrier function, cytokine modulation, and localized inflammatory response mechanisms across multiple tissue types

The mean percentage change in body weight from baseline to 68 weeks was 14.9% in the semaglutide group versus 2.4% in the placebo group

You can read it here

Approximately 85% of GLP-1 users report significant taste and appetite changes, with 74% actively avoiding fatty foods and 67% skipping sweets entirely, a study by International Flavors & Fragrances (IFF) noted. Marketing assumes that a desire to consume food exists, Srinivasan notes

BPC 157, a synthetic peptide derived from a naturally occurring protein in the stomach, has garnered attention for its potential benefits in muscle recovery and growth

J Rheumatol Suppl